Network pharmacology-based strategy for predicting therapy targets of Ecliptae Herba on breast cancer

被引:13
|
作者
Li, Hui [1 ,2 ,3 ]
Shi, Wei [1 ,2 ,3 ]
Shen, Tingming [4 ]
Hui, Siwen [2 ,3 ]
Hou, Manting [2 ,3 ]
Wei, Ziying [1 ,2 ,3 ]
Qin, Shuanglin [5 ]
Bai, Zhaofang [2 ,3 ]
Cao, Junling [1 ,6 ]
机构
[1] Beijing Univ Chinese Med, Sch Chinese Mat Med, Beijing 102488, Peoples R China
[2] Chinese Peoples Liberat Army Gen Hosp, Med Ctr 5, Dept Hepatol, Beijing, Peoples R China
[3] Chinese Peoples Liberat Army Gen Hosp, China Mil Inst Chinese Mat, Med Ctr 5, Beijing, Peoples R China
[4] Ningde Hosp Tradit Chinese Med, Ningde, Peoples R China
[5] Hubei Univ Sci & Technol, Xianning Med Coll, Sch Pharm, Xianning, Peoples R China
[6] Beijing Univ Chinese Med, Dongzhimen Hosp, Luoyang Branch, Beijing, Peoples R China
基金
中国博士后科学基金; 中国国家自然科学基金;
关键词
breast cancer; Ecliptae Herba; molecular docking; network pharmacology; TGF-beta; 1; MESENCHYMAL TRANSITION; CELL-PROLIFERATION; STEM-CELLS; TGF-BETA; METASTASIS; RESOURCE; EXTRACT;
D O I
10.1097/MD.0000000000035384
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Breast cancer is a prevalent malignancy affecting women globally, characterized by significant morbidity and mortality rates. Ecliptae Herba is a traditional herbal medicine commonly used in clinical practice, has recently been found to possess antitumor properties. In order to explore the underlying material basis and molecular mechanisms responsible for the anti-breast cancer effects of Ecliptae Herba, we used network pharmacology and experimental verification. UPLC-MS/MS was utilized to identify compounds present in Ecliptae Herba. The active components of Ecliptae Herba and its breast cancer targets were screened using public databases. Hub genes were identified using the STRING and Metascape database. The R software was utilized for visual analysis of GO and KEGG pathways. The affinity of the hub targets for the active ingredients was assessed by molecular docking analysis, which was verified by experimental assessment. A total of 178 targets were obtained from the 10 active components of Ecliptae Herba, while 3431 targets associated with breast cancer were screened. There were 144 intersecting targets between the components and the disease. Targets with a higher degree, namely EGFR and TGFB1, were identified through the hub subnetwork of PPI. GO and KEGG analyses revealed that Ecliptae Herba plays an important role in multiple cancer therapeutic mechanisms. Moreover, molecular docking results showed that the core components had good binding affinity with key targets. Finally, it was confirmed that TGF-beta 1 might be a potential crucial target of Ecliptae Herba in the treatment of breast cancer by cytological experiments, and the TGF-beta 1/Smad signaling pathway might be an important pathway for Ecliptae Herba to exert its therapeutic effects. This study elucidated the active ingredients, key targets, and molecular mechanisms of Ecliptae Herba in the treatment of breast cancer, providing a scientific foundation and therapeutic mechanism for the prevention and treatment of breast cancer with Traditional Chinese medicine.
引用
收藏
页数:12
相关论文
共 50 条
  • [41] A network pharmacology-based approach to explore the molecular mechanism of Aidi injection against prostate cancer
    Guo, Sheng
    Zhang, Qiuping
    Li, Xiaolan
    Yu, Xiaoxiang
    Lan, Taijin
    Zhang, Weiquan
    Han, Yaoyao
    Chen, Xin
    Yang, Xin
    Guo, Hongwei
    HELIYON, 2024, 10 (08)
  • [42] Network Pharmacology-based Strategy to Investigate Pharmacological Mechanisms of Qingbutongluo Pill for Treatment of Brucellosis
    Wang, Jing
    He, Jia-Wei
    Liu, Ji-Shan
    Li, Jian-E
    Cui, Qing-You
    Wang, Yi-Rui
    Zhou, Wei-Gang
    COMBINATORIAL CHEMISTRY & HIGH THROUGHPUT SCREENING, 2023, 26 (04) : 706 - 718
  • [43] Network pharmacology-based prediction and verification of the molecular targets and pathways for schisandrin against cerebrovascular disease
    Lv Yan-Ni
    Li Shao-Xia
    Zhai Ke-Feng
    Kou Jun-Ping
    Yu Bo-Yang
    CHINESE JOURNAL OF NATURAL MEDICINES, 2014, 12 (04) : 251 - 258
  • [44] Network Pharmacology-Based Validation of Caveolin-1 as a Key Mediator of Ai Du Qing Inhibition of Drug Resistance in Breast Cancer
    Wang, Neng
    Yang, Bowen
    Zhang, Xiaotong
    Wang, Shengqi
    Zheng, Yifeng
    Li, Xiong
    Liu, Shan
    Pan, Hao
    Li, Yingwei
    Huang, Zhujuan
    Zhang, Fengxue
    Wang, Zhiyu
    FRONTIERS IN PHARMACOLOGY, 2018, 9
  • [45] Meta-analysis and network pharmacology-based investigation of Shenqi Fuzheng injection plus docetaxel for the efficacy and molecular mechanism of breast cancer
    Luo, Yanqiong
    Hou, Yujiao
    Li, Qian
    Zhang, Han
    Njolibimi, Moses Manaanye
    Li, Wenjing
    Hong, Bo
    EUROPEAN JOURNAL OF INTEGRATIVE MEDICINE, 2024, 67
  • [46] Network pharmacology-based prediction and verification of the molecular targets and pathways for schisandrin against cerebrovascular disease
    LV Yan-Ni
    LI Shao-Xia
    ZHAI Ke-Feng
    KOU Jun-Ping
    YU Bo-Yang
    Chinese Journal of Natural Medicines, 2014, 12 (04) : 251 - 258
  • [47] Analysis of pharmacological mechanisms of Yinyanghuo as treatment of erectile dysfunction with network pharmacology-based strategy
    Yang, Xudong
    Cui, Yuanshan
    Zhou, Zhongbao
    Zhao, Huishan
    Zhang, Yong
    ANDROLOGIA, 2021, 53 (02)
  • [48] Molecular targets of metformin against ovarian cancer based on network pharmacology
    Guo, Jia-yi
    Wang, Yong-jun
    Li, Si-qi
    Wu, Yu-ping
    CHEMICAL BIOLOGY & DRUG DESIGN, 2023, 102 (01) : 88 - 100
  • [49] Theoretical Study of the Molecular Mechanism of Maxingyigan Decoction Against COVID-19: Network Pharmacology-based Strategy
    Wang, Mingzhu
    Fu, Deyu
    Yao, Lei
    Li, Jianhua
    COMBINATORIAL CHEMISTRY & HIGH THROUGHPUT SCREENING, 2021, 24 (02) : 294 - 305
  • [50] A network pharmacology-based study on key pharmacological pathways and targets of Qi Fu Yin acting on Alzheimer's disease
    Xiao, Qiu-yue
    Ye, Tian-yuan
    Wang, Xiao-long
    Han, Lu
    Wang, Tong-xing
    Qi, Dong-mei
    Cheng, Xiao-rui
    Wang, Sheng-qi
    EXPERIMENTAL GERONTOLOGY, 2021, 149